The increase in RDW may be related to a variety of potential metabolic abnormalities, such as inflammation, oxidative stress, telomere shortening, malnutrition, dyslipidemia, hypertension, erythrocyte fragmentation, and abnormality of erythropoietin function [17]. This evidence concerns the gene EPO and metabolic syndrome.